LVDAO Terazosin Hydrochloride Tablets For Prostate Issues 2mg*28

(No reviews yet) Write a Review
$16.99
Origin:
China
Manufacturer:
LVDAO
Form:
Tablets
Specification:
2mg*28
Storage Life:
42 months
Adding to cart… The item has been added

Product Overview

[Drug name]
Generic name: H terazosin hydrochloride tablets
Trade name: H terazosin hydrochloride tablets 2mg*14 tablets*2 plates
Pinyin full code: HYanSuanTeLaZuoZuoPian 2mg*14Pian*2Ban
[Main ingredients]
Active ingredient: terazosin hydrochloride. Chemical name: 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(tetrahydro-2-furanoyl)piperazine hydrochloride dihydrate. Molecular formula:
C19H25N5O4·HCI·2H2OMolecular weight: 459.93Excipients: lactose, pregelatinized starch, microcrystalline cellulose, sodium carboxymethyl cellulose, magnesium stearate.
[Properties]
This product is white or off-white tablets.
[Indications/Main Functions]
This product is suitable for the treatment of mild or moderate hypertension when taken orally. It can be used in combination with thiazide diuretics or other antihypertensive drugs. It can also be used alone when other drugs are not suitable or ineffective. This product mainly reduces diastolic blood pressure. This product is also suitable for the treatment of symptoms caused by benign prostatic hyperplasia (BPH) when taken orally.
[Specifications]
2mg*14 tablets*2 plates
[Usage and Dosage]
The initial dose for hypertension is 1 mg before bedtime, and should not be exceeded to minimize the occurrence of hypotension events at the first dose. After one week, the daily single dose can be doubled to achieve the expected effect. The commonly used maintenance dose is 2-10 mg once a day. No increase in efficacy has been observed with doses exceeding 20 mg, and no studies have been conducted on doses above 40 mg. Benign prostatic hyperplasia (BPH) The dosage is adjusted according to the patient's response. The initial dose is 1 mg before bedtime, and should not be exceeded to minimize the occurrence of hypotension events at the first dose. After one or two weeks, the daily dose can be doubled to achieve the expected effect. The commonly used maintenance dose is 5-10 mg once a day. Symptoms are significantly improved after two weeks of administration. So far, there is not enough data to show that doses exceeding 10 mg once a day will cause further symptom relief. Treatment should be started with the initial dose and the efficacy summary should be conducted after four weeks. Temporary adverse reactions may occur with each dose adjustment. If adverse reactions persist, a reduction in the dosage should be considered.
[Adverse Reactions]
See the instructions for details.
[Contraindications]
This product is contraindicated for those who are allergic to terazosin hydrochloride or its analogs.
【Precautions】
See the instruction manual for details.

Reviews

(No reviews yet) Write a Review